spacer
spacer
Go to PDB code: 
protein ligands Protein-protein interface(s) links
Growth factor/growth factor receptor PDB-id
1evt
Biological unit* = asymmetric unit,
as shown
(*as deduced by PQS)
    Jmol     Help!  
Contents
Description
Header details
Header records
References
PROCHECK
Protein chains
131 a.a. *
191 a.a. *
Ligands
SO4 ×4

* Residue conservation analysis
Tools
Image Generation
AstexViewer™@PDBe
Run PROCHECK
Clefts Calculation
  
PDB id: 1evt
Name: Growth factor/growth factor receptor
Title: Crystal structure of fgf1 in complex with the extracellular ligand binding domain of fgf receptor 1 (fgfr1)

Structure:
Protein (fibroblast growth factor 1). Chain: a, b. Fragment: the b-trefoil core of fibroblast growth factor 1 (fgf1). Synonym: fgf1. Engineered: yes. Protein (fibroblast growth factor receptor 1). Chain: c, d. Fragment: extracellular ligand binding domain of fgf

Source:
Homo sapiens. Human. Organism_taxid: 9606. Expressed in: bacteria. Expression_system_taxid: 2. Expression_system_taxid: 2

Biological unit:
Tetramer (from PQS)

UniProt:
Chains A, B: P05230 (FGF1_HUMAN)
Pfam  
Seq: 155 a.a.
Struc: 131 a.a.

Chains C, D: P11362 (FGFR1_HUMAN)
Pfam  
Seq:
Struc:
Seq:
Struc:
Seq:
Struc:
Seq: 822 a.a.
Struc: 191 a.a.
Key:    PfamA domain
 Secondary structure  CATH domain

Enzyme class:
Chains C, D: E.C.2.7.10.1   [IntEnz]   [ExPASy]   [KEGG]   [BRENDA]

Reaction:
ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate

Resolution:
2.80Å

R-factor:
0.249

R-free:
0.300

Authors:
A.N.Plotnikov,S.R.Hubbard,J.Schlessinger,M.Mohammadi

Key ref:
A.N.Plotnikov et al. (2000). Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.. Cell, 101, 413-424. [PubMed id: 10830168] [DOI: 10.1016/S0092-8674(00)80851-X]

Date:
20-Apr-00

Release date:
31-May-00

Related entries:
1cvs
crystal structure of fgf2 in complex with the extracellular
ligand binding domain of fgf receptor 1 (fgfr1)
1evt
fgf1-fgfr1 complex
Quick_links
RCSB
PDBe
SRS
MMDB
JenaLib
OCA
Proteopedia
CATH
SCOP
FSSP
HSSP
PDBSWS
PQS
ProSAT
Whatcheck
Procheck
Go to PROCHECK summary
Surface
RasMol surface
spacer
spacer

 
    Key reference    
 
 
DOI no: 10.1016/S0092-8674(00)80851-X Cell 101:413-424 (2000)
PubMed id: 10830168  
 
 
Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.
A.N.Plotnikov, S.R.Hubbard, J.Schlessinger, M.Mohammadi.
 
  ABSTRACT  
 
To elucidate the structural determinants governing specificity in fibroblast growth factor (FGF) signaling, we have determined the crystal structures of FGF1 and FGF2 complexed with the ligand binding domains (immunoglobulin-like domains 2 [D2] and 3 [D3]) of FGF receptor 1 (FGFR1) and FGFR2, respectively. Highly conserved FGF-D2 and FGF-linker (between D2-D3) interfaces define a general binding site for all FGF-FGFR complexes. Specificity is achieved through interactions between the N-terminal and central regions of FGFs and two loop regions in D3 that are subject to alternative splicing. These structures provide a molecular basis for FGF1 as a universal FGFR ligand and for modulation of FGF-FGFR specificity through primary sequence variations and alternative splicing.
 
  Selected figure(s)  
 
Figure 3.
Figure 3. Detailed Interactions between FGF and FGFR in the FGF-D2 and FGF-Linker Interfaces(A) Stereo view of the hydrophobic interface between FGF2 and D2 of FGFR2.(B) Stereo view of the hydrophobic interface between FGF1 and D2 of FGFR1.(C) Stereo view of the conserved network of hydrogen bonds between FGF2 and FGFR2 in the vicinity of Arg-251 in the D2-D3 linker.(D) Stereo view of the network of hydrogen bonds between FGF1 and FGFR1 in the vicinity of Arg-250 in the D2-D3 linker. Only side chains of interacting residues are shown. At the right side of each stereo pair, a view of the whole structure in the exact orientation as in stereo views is shown, and the region of interest is highlighted. Color coding is the same as in Figure 1: FGF1 and FGF2 in orange, D2 in green, D3 in cyan, and the linker in gray. Oxygen atoms are colored red, nitrogen atoms blue, and carbon atoms have the same coloring as the molecules to which they belong. Dotted lines represent hydrogen bonds. This figure was created using the programs Molscript and Raster3D.
Figure 4.
Figure 4. Detailed Interactions between FGF and FGFR in the FGF-D3 Interfaces(A) Stereo view of the interface between FGF2 and the βF-βG loop of D3 in the FGF2-FGFR2 structure.(B) Stereo view of the interface between N-terminal sequences (prior to β1) of FGF2 and D3 in the FGF2-FGFR2 structure.(C) Stereo view of the interface between FGF2 and the βC′-βE segment (shown in purple) of D3 in the FGF2-FGFR2 structure.(D) Stereo view of the interface between FGF1 and D3 in the FGF1-FGFR1 structure. At the right side of each stereo pair, a view of the whole structure in the exact orientation as in stereo views is shown, and the region of interest is highlighted. Only side chains of interacting residues are shown. Color coding is the same as in Figure 3. Dotted lines represent hydrogen bonds. This figure was created using the programs Molscript and Raster3D.
 
  The above figures are reprinted by permission from Cell Press: Cell (2000, 101, 413-424) copyright 2000.  
  Figures were selected by the author.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
18726952 E.G.Bochukova, T.Roscioli, D.J.Hedges, I.B.Taylor, D.Johnson, D.J.David, P.L.Deininger, and A.O.Wilkie (2009).
Rare mutations of FGFR2 causing apert syndrome: identification of the first partial gene deletion, and an Alu element insertion from a new subfamily.
  Hum Mutat, 30, 204-211.  
19658168 E.Stuttfeld, and K.Ballmer-Hofer (2009).
Structure and function of VEGF receptors.
  IUBMB Life, 61, 915-922.  
19574212 M.Zakrzewska, A.Wiedlocha, A.Szlachcic, D.Krowarsch, J.Otlewski, and S.Olsnes (2009).
Increased protein stability of FGF1 can compensate for its reduced affinity for heparin.
  J Biol Chem, 284, 25388-25403.  
19634127 S.Li, C.Christensen, L.B.Køhler, V.V.Kiselyov, V.Berezin, and E.Bock (2009).
Agonists of fibroblast growth factor receptor induce neurite outgrowth and survival of cerebellar granule neurons.
  Dev Neurobiol, 69, 837-854.  
18846105 A.R.Grosso, S.Martins, and M.Carmo-Fonseca (2008).
The emerging role of splicing factors in cancer.
  EMBO Rep, 9, 1087-1093.  
18826624 K.Chen, Y.Ohkubo, D.Shin, T.Doetschman, L.P.Sanford, H.Li, and F.M.Vaccarino (2008).
Decrease in excitatory neurons, astrocytes and proliferating progenitors in the cerebral cortex of mice lacking exon 3 from the Fgf2 gene.
  BMC Neurosci, 9, 94.  
17705152 S.B.Joshi, T.J.Kamerzell, C.McNown, and C.R.Middaugh (2008).
The interaction of heparin/polyanions with bovine, porcine, and human growth hormone.
  J Pharm Sci, 97, 1368-1385.  
18441324 S.Mori, C.Y.Wu, S.Yamaji, J.Saegusa, B.Shi, Z.Ma, Y.Kuwabara, K.S.Lam, R.R.Isseroff, Y.K.Takada, and Y.Takada (2008).
Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling.
  J Biol Chem, 283, 18066-18075.  
18523850 S.Oltean, P.G.Febbo, and M.A.Garcia-Blanco (2008).
Dunning rat prostate adenocarcinomas and alternative splicing reporters: powerful tools to study epithelial plasticity in prostate tumors in vivo.
  Clin Exp Metastasis, 25, 611-619.  
17623664 H.Kurosu, M.Choi, Y.Ogawa, A.S.Dickson, R.Goetz, A.V.Eliseenkova, M.Mohammadi, K.P.Rosenblatt, S.A.Kliewer, and M.Kuro-o (2007).
Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
  J Biol Chem, 282, 26687-26695.  
17637802 I.Mason (2007).
Initiation to end point: the multiple roles of fibroblast growth factors in neural development.
  Nat Rev Neurosci, 8, 583-596.  
  17277441 N.Kulahin, V.Kiselyov, A.Kochoyan, O.Kristensen, J.S.Kastrup, V.Berezin, E.Bock, and M.Gajhede (2007).
Structure of rat acidic fibroblast growth factor at 1.4 A resolution.
  Acta Crystallogr Sect F Struct Biol Cryst Commun, 63, 65-68.
PDB code: 2j3p
17339340 R.Goetz, A.Beenken, O.A.Ibrahimi, J.Kalinina, S.K.Olsen, A.V.Eliseenkova, C.Xu, T.A.Neubert, F.Zhang, R.J.Linhardt, X.Yu, K.E.White, T.Inagaki, S.A.Kliewer, M.Yamamoto, H.Kurosu, Y.Ogawa, M.Kuro-o, B.Lanske, M.S.Razzaque, and M.Mohammadi (2007).
Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
  Mol Cell Biol, 27, 3417-3428.
PDB codes: 2p23 2p39
17525467 T.J.Kamerzell, S.B.Joshi, D.McClean, L.Peplinskie, K.Toney, D.Papac, M.Li, and C.R.Middaugh (2007).
Parathyroid hormone is a heparin/polyanion binding protein: binding energetics and structure modification.
  Protein Sci, 16, 1193-1203.  
17452648 Y.Ogawa, H.Kurosu, M.Yamamoto, A.Nandi, K.P.Rosenblatt, R.Goetz, A.V.Eliseenkova, M.Mohammadi, and M.Kuro-o (2007).
BetaKlotho is required for metabolic activity of fibroblast growth factor 21.
  Proc Natl Acad Sci U S A, 104, 7432-7437.  
17632321 Z.Liu, T.Ishiwata, S.Zhou, S.Maier, D.Henne-Bruns, M.Korc, M.Bachem, and M.Kornmann (2007).
Human fibroblast growth factor receptor 1-IIIb is a functional fibroblast growth factor receptor expressed in the pancreas and involved in proliferation and movement of pancreatic ductal cells.
  Pancreas, 35, 147-157.  
16857011 A.Winter, A.M.Yusof, E.Gao, H.L.Yan, S.H.Sun, and A.Hofmann (2006).
Biochemical characterization of annexin B1 from Cysticercus cellulosae.
  FEBS J, 273, 3238-3247.  
  17048306 D.Li, Q.Q.Wang, G.P.Tang, H.L.Huang, F.P.Shen, J.Z.Li, and H.Yu (2006).
Receptor-mediated gene delivery using polyethylenimine (PEI) coupled with polypeptides targeting FGF receptors on cells surface.
  J Zhejiang Univ Sci B, 7, 906-911.  
16470795 E.G.Farrow, S.I.Davis, S.D.Mooney, P.Beighton, L.Mascarenhas, Y.R.Gutierrez, P.Pitukcheewanont, and K.E.White (2006).
Extended mutational analyses of FGFR1 in osteoglophonic dysplasia.
  Am J Med Genet A, 140, 537-539.  
17005551 E.Sanchez-Heras, F.V.Howell, G.Williams, and P.Doherty (2006).
The fibroblast growth factor receptor acid box is essential for interactions with N-cadherin and all of the major isoforms of neural cell adhesion molecule.
  J Biol Chem, 281, 35208-35216.  
16829530 L.Duchesne, B.Tissot, T.R.Rudd, A.Dell, and D.G.Fernig (2006).
N-glycosylation of fibroblast growth factor receptor 1 regulates ligand and heparan sulfate co-receptor binding.
  J Biol Chem, 281, 27178-27189.  
16849318 P.R.Macdonald, P.Progias, B.Ciani, S.Patel, U.Mayer, M.O.Steinmetz, and R.A.Kammerer (2006).
Structure of the extracellular domain of Tie receptor tyrosine kinases and localization of the angiopoietin-binding epitope.
  J Biol Chem, 281, 28408-28414.  
16796457 P.Wei, J.Zhan, S.Liu, D.Chang, R.Haldankar, K.Burkhardt, J.Crouse, J.Hui, T.Juan, J.Talvenheimo, H.Kim, L.Li, T.Boone, and L.Borges (2006).
Generation and characterization of monoclonal antibodies to human keratinocyte growth factor receptor.
  Hybridoma (Larchmt), 25, 115-124.  
16834555 R.Sasisekharan, R.Raman, and V.Prabhakar (2006).
Glycomics approach to structure-function relationships of glycosaminoglycans.
  Annu Rev Biomed Eng, 8, 181-231.  
16384934 S.K.Olsen, J.Y.Li, C.Bromleigh, A.V.Eliseenkova, O.A.Ibrahimi, Z.Lao, F.Zhang, R.J.Linhardt, A.L.Joyner, and M.Mohammadi (2006).
Structural basis by which alternative splicing modulates the organizer activity of FGF8 in the brain.
  Genes Dev, 20, 185-198.
PDB code: 2fdb
17132737 V.P.Eswarakumar, F.Ozcan, E.D.Lew, J.H.Bae, F.Tomé, C.J.Booth, D.J.Adams, I.Lax, and J.Schlessinger (2006).
Attenuation of signaling pathways stimulated by pathologically activated FGF-receptor 2 mutants prevents craniosynostosis.
  Proc Natl Acad Sci U S A, 103, 18603-18608.  
17008716 V.V.Kiselyov, A.Kochoyan, F.M.Poulsen, E.Bock, and V.Berezin (2006).
Elucidation of the mechanism of the regulatory function of the Ig1 module of the fibroblast growth factor receptor 1.
  Protein Sci, 15, 2318-2322.  
16731982 V.V.Kiselyov, E.Bock, V.Berezin, and F.M.Poulsen (2006).
NMR structure of the first Ig module of mouse FGFR1.
  Protein Sci, 15, 1512-1515.
PDB code: 2ckn
16219767 C.J.Robinson, N.J.Harmer, S.J.Goodger, T.L.Blundell, and J.T.Gallagher (2005).
Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes.
  J Biol Chem, 280, 42274-42282.  
15879597 F.Soulet, K.Bailly, S.Roga, A.C.Lavigne, F.Amalric, and G.Bouche (2005).
Exogenously added fibroblast growth factor 2 (FGF-2) to NIH3T3 cells interacts with nuclear ribosomal S6 kinase 2 (RSK2) in a cell cycle-dependent manner.
  J Biol Chem, 280, 25604-25610.  
16373575 G.G.Whitehead, S.Makino, C.L.Lien, and M.T.Keating (2005).
fgf20 is essential for initiating zebrafish fin regeneration.
  Science, 310, 1957-1960.  
15632068 O.A.Ibrahimi, B.K.Yeh, A.V.Eliseenkova, F.Zhang, S.K.Olsen, M.Igarashi, S.A.Aaronson, R.J.Linhardt, and M.Mohammadi (2005).
Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization.
  Mol Cell Biol, 25, 671-684.  
16081654 V.K.Dubey, J.Lee, and M.Blaber (2005).
Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.
  Protein Sci, 14, 2315-2323.  
15674480 B.Kaur, C.Tan, D.J.Brat, D.E.Post, and E.G.Van Meir (2004).
Genetic and hypoxic regulation of angiogenesis in gliomas.
  J Neurooncol, 70, 229-243.  
15365636 C.Dodé, and J.P.Hardelin (2004).
Kallmann syndrome: fibroblast growth factor signaling insufficiency?
  J Mol Med, 82, 725-734.  
15334457 K.Nakano, Y.Okada, K.Saito, and Y.Tanaka (2004).
Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts.
  Arthritis Rheum, 50, 2450-2458.  
14660620 K.Nogami, H.Suzuki, H.Habuchi, N.Ishiguro, H.Iwata, and K.Kimata (2004).
Distinctive expression patterns of heparan sulfate O-sulfotransferases and regional differences in heparan sulfate structure in chick limb buds.
  J Biol Chem, 279, 8219-8229.  
14976206 L.Volpon, H.Lamthanh, J.Barbier, N.Gilles, J.Molgó, A.Ménez, and J.M.Lancelin (2004).
NMR solution structures of delta-conotoxin EVIA from Conus ermineus that selectively acts on vertebrate neuronal Na+ channels.
  J Biol Chem, 279, 21356-21366.
PDB codes: 1g1p 1g1z
14993768 N.Numao, H.Fujii, Y.Fukazawa, N.Hanagata, and K.Tanaka (2004).
Hydrophobic scale: a second parameter to elucidating various specific ligand-protein interactions.
  Chem Pharm Bull (Tokyo), 52, 377-379.  
14707131 S.Ashikari-Hada, H.Habuchi, Y.Kariya, N.Itoh, A.H.Reddi, and K.Kimata (2004).
Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library.
  J Biol Chem, 279, 12346-12354.  
14732692 S.K.Olsen, O.A.Ibrahimi, A.Raucci, F.Zhang, A.V.Eliseenkova, A.Yayon, C.Basilico, R.J.Linhardt, J.Schlessinger, and M.Mohammadi (2004).
Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity.
  Proc Natl Acad Sci U S A, 101, 935-940.
PDB code: 1ry7
15051888 S.Wang, X.Ai, S.D.Freeman, M.E.Pownall, Q.Lu, D.S.Kessler, and C.P.Emerson (2004).
QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis.
  Proc Natl Acad Sci U S A, 101, 4833-4838.  
12496262 A.Facchiano, K.Russo, A.M.Facchiano, F.De Marchis, F.Facchiano, D.Ribatti, M.S.Aguzzi, and M.C.Capogrossi (2003).
Identification of a novel domain of fibroblast growth factor 2 controlling its angiogenic properties.
  J Biol Chem, 278, 8751-8760.  
12591959 B.K.Yeh, M.Igarashi, A.V.Eliseenkova, A.N.Plotnikov, I.Sher, D.Ron, S.A.Aaronson, and M.Mohammadi (2003).
Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors.
  Proc Natl Acad Sci U S A, 100, 2266-2271.
PDB code: 1nun
14502567 C.Ito, Y.Saitoh, Y.Fujita, Y.Yamazaki, T.Imamura, S.Oka, and S.Suzuki (2003).
Decapeptide with fibroblast growth factor (FGF)-5 partial sequence inhibits hair growth suppressing activity of FGF-5.
  J Cell Physiol, 197, 272-283.  
12960434 Q.Shi, and D.Boettiger (2003).
A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397.
  Mol Biol Cell, 14, 4306-4315.  
12815063 S.K.Olsen, M.Garbi, N.Zampieri, A.V.Eliseenkova, D.M.Ornitz, M.Goldfarb, and M.Mohammadi (2003).
Fibroblast growth factor (FGF) homologous factors share structural but not functional homology with FGFs.
  J Biol Chem, 278, 34226-34236.
PDB code: 1q1u
14745970 X.Coumoul, and C.X.Deng (2003).
Roles of FGF receptors in mammalian development and congenital diseases.
  Birth Defects Res C Embryo Today, 69, 286-304.  
12604602 Z.L.Wu, L.Zhang, T.Yabe, B.Kuberan, D.L.Beeler, A.Love, and R.D.Rosenberg (2003).
The involvement of heparan sulfate (HS) in FGF1/HS/FGFR1 signaling complex.
  J Biol Chem, 278, 17121-17129.  
12205097 A.I.Arunkumar, S.Srisailam, T.K.Kumar, K.M.Kathir, Y.H.Chi, H.M.Wang, G.G.Chang, I.Chiu, and C.Yu (2002).
Structure and stability of an acidic fibroblast growth factor from Notophthalmus viridescens.
  J Biol Chem, 277, 46424-46432.
PDB code: 1fmm
11967362 A.I.Arunkumar, T.K.Kumar, K.M.Kathir, S.Srisailam, H.M.Wang, P.S.Leena, Y.H.Chi, H.C.Chen, C.H.Wu, R.T.Wu, G.G.Chang, I.M.Chiu, and C.Yu (2002).
Oligomerization of acidic fibroblast growth factor is not a prerequisite for its cell proliferation activity.
  Protein Sci, 11, 1050-1061.  
12357470 A.O.Wilkie, S.J.Patey, S.H.Kan, A.M.van den Ouweland, and B.C.Hamel (2002).
FGFs, their receptors, and human limb malformations: clinical and molecular correlations.
  Am J Med Genet, 112, 266-278.  
12242295 B.K.Yeh, A.V.Eliseenkova, A.N.Plotnikov, D.Green, J.Pinnell, T.Polat, A.Gritli-Linde, R.J.Linhardt, and M.Mohammadi (2002).
Structural basis for activation of fibroblast growth factor signaling by sucrose octasulfate.
  Mol Cell Biol, 22, 7184-7192.  
12077148 B.M.Loo, and M.Salmivirta (2002).
Heparin/Heparan sulfate domains in binding and signaling of fibroblast growth factor 8b.
  J Biol Chem, 277, 32616-32623.  
12045103 J.D.Esko, and S.B.Selleck (2002).
Order out of chaos: assembly of ligand binding sites in heparan sulfate.
  Annu Rev Biochem, 71, 435-471.  
11972061 P.Aloy, and R.B.Russell (2002).
Interrogating protein interaction networks through structural biology.
  Proc Natl Acad Sci U S A, 99, 5896-5901.  
12000365 T.J.Wang, C.B.Huang, F.J.Tsai, J.Y.Wu, R.B.Lai, and M.Hsiao (2002).
Mutation in the FGFR2 gene in a Taiwanese patient with Beare-Stevenson cutis gyrata syndrome.
  Clin Genet, 61, 218-221.  
11746231 C.Z.Borland, J.L.Schutzman, and M.J.Stern (2001).
Fibroblast growth factor signaling in Caenorhabditis elegans.
  Bioessays, 23, 1120-1130.  
  11276432 D.M.Ornitz, and N.Itoh (2001).
Fibroblast growth factors.
  Genome Biol, 2, REVIEWS3005.  
11571292 E.J.Williams, G.Williams, F.V.Howell, S.D.Skaper, F.S.Walsh, and P.Doherty (2001).
Identification of an N-cadherin motif that can interact with the fibroblast growth factor receptor and is required for axonal growth.
  J Biol Chem, 276, 43879-43886.  
11223514 H.J.Hecht, R.Adar, B.Hofmann, O.Bogin, H.Weich, and A.Yayon (2001).
Structure of fibroblast growth factor 9 shows a symmetric dimer with unique receptor- and heparin-binding interfaces.
  Acta Crystallogr D Biol Crystallogr, 57, 378-384.
PDB code: 1g82
11737582 K.E.White, G.Carn, B.Lorenz-Depiereux, A.Benet-Pages, T.M.Strom, and M.J.Econs (2001).
Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23.
  Kidney Int, 60, 2079-2086.  
11390973 O.A.Ibrahimi, A.V.Eliseenkova, A.N.Plotnikov, K.Yu, D.M.Ornitz, and M.Mohammadi (2001).
Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.
  Proc Natl Acad Sci U S A, 98, 7182-7187.
PDB codes: 1ii4 1iil
11486033 P.Bellosta, A.Iwahori, A.N.Plotnikov, A.V.Eliseenkova, C.Basilico, and M.Mohammadi (2001).
Identification of receptor and heparin binding sites in fibroblast growth factor 4 by structure-based mutagenesis.
  Mol Cell Biol, 21, 5946-5957.
PDB code: 1ijt
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.